Racial and ethnic disparities in cardiovascular medication use among older adults in the United States

Pharmacoepidemiology and Drug Safety

Volumn 19, Issue 8, 2010, Pages 834-842

  Qato, Dima M ^a,b   Lindau, Stacy Tessler ^a,c   Conti, Rena M ^a,d   Schumm, L Philip ^a   Alexander, G Caleb ^a,b,c,d  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

Disparities; Geriatrics; Race ethnicity; Secondary prevention; Statins

Indexed keywords

ACETYLSALICYLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NON PRESCRIPTION DRUG;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMORBIDITY; DRUG UTILIZATION; ETHNIC DIFFERENCE; FEMALE; HEALTH CARE ACCESS; HEALTH INSURANCE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; RACE DIFFERENCE; SECONDARY PREVENTION; SOCIOECONOMICS;

AGED; AGED, 80 AND OVER; ASPIRIN; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; COMORBIDITY; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 77956629843     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1974     Document Type: Article

References (54)

1. Qato DM, Alexander GC, Conti RM, Johnson M, Schumm P, Lindau ST. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA 2008; 300(24): 2867-2878.
2. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285(19): 2486-2497.
3. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110(2): 227-239.
4. Hebert PR, Pfeffer MA, Hennekens CH. Use of statins and aspirin to reduce risks of cardiovascular disease. J Cardiovasc Pharmacol Ther 2002; 7(2): 77-80.
5. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics - 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009; 119(3): e21-e181.
6. Mensah GA, Brown DW. An overview of cardiovascular disease burden in the United States. Health Aff (Millwood) 2007; 26(1): 38-48.
7. Unequal Treatment: Confronting Racial & Ethnic Disparities in Health Care. Institute of Medicine. 2003.
8. Agency for Heathcare Research and Quality. National Healthcare Disparities Report. Department of Health and Human Services AfHRaQW, DC: 2006. National Healthcare Disparities Report. Washington, DC.
9. Mensah GA, Mokdad AH, Ford ES, Greenlund KJ, Croft JB. State of disparities in cardiovascular health in the United States. Circulation 2005; 111(10): 1233-1241.
10. Davis AM, Vinci LM, Okwuosa TM, Chase AR, Huang ES. Cardiovascular health disparities: a systematic review of health care interventions. Med Care Res Rev 2007; 64(5 Suppl): 29S-100S.
11. Weisman SM, Graham DY. Evaluation of the benefits and risks of lowdose aspirin in the secondary prevention of cardiovascular and cerebrovascular events. Arch Intern Med 2002; 162(19): 2197-2202.
12. Mann D, Reynolds K, Smith D, Muntner P. Trends in statin use and lowdensity lipoprotein cholesterol levels among U.S. adults: impact of the 2001 national cholesterol education program guidelines. Ann Pharmacother 2008; 42: 1208-1215.
13. Ma J, Sehgal NL, Ayanian JZ, Stafford RS. National trends in statin use by coronary heart disease risk category. PLoS Med 2005; 2(5): e123.
14. Setoguchi S, Glynn RJ, Avorn J, Levin R, Winkelmayer WC. Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons or = 65 years of age. Am J Cardiol 2007; 100(7): 1061-1067.
15. Brown DW, Shepard D, Giles WH, Greenlund KJ, Croft JB. Racial differences in the use of aspirin: an important tool for preventing heart disease and stroke. Ethn Dis 2005; 15(4): 620-626.
16. Ford ES, Li C, Pearson WS, Zhao G, Mokdad AH. Trends in hypercholesterolemia, treatment and control among United States adults. Int J Cardiol 2010; 140(2): 226-235. Epub 2008 Dec 10.
17. Ajani UA, Ford ES, Greenland KJ, Giles WH, Mokdad AH. Aspirin use among U.S. adults: Behavioral Risk Factor Surveillance System. Am J Prev Med 2006; 30(1): 74-77.
18. Smith NL, Psaty BM, Heckbert SR, Tracy RP, Cornell ES. The reliability of medication inventory methods compared to serum levels of cardiovascular drugs in the elderly. J Clin Epidemiol 1999; 52(2): 143-146.
19. Qato DM, Schumm LP, Johnson M, Mihai A, Lindau ST. Medication data collection and coding in a home-based survey of older adults. J Gerontol B Psychol Sci Soc Sci 2009; 64 (Suppl 1): i86-93.
20. Benner JS, Glynn RJ, Mogun H, Neumann PJ,Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002; 288(4): 455-461.
21. Lindau ST, Schumm LP, Laumann EO, LevinsonW, O'Muircheartaigh CA,Waite LJ. A study of sexuality and health among older adults in the United States. N Engl J Med 2007; 357(8): 762-774.
22. O'Muircheartaigh C, Eckman S, Smith S. Statistical design and estimation for the national social life, health, and aging project. J Gerontol B Psychol Sci Soc Sci 2009; 64 (Suppl 1): i12-i19.
23. Kalton G, Kasprzyk D. The treatment of missing survey data. Surv Methodol 1986; 12: 1-16.
24. Qato DM, Schumm LP, Johnson M, Mihai A, Lindau ST. Medication data collection and coding in a home-based survey of older adults. J Gerontol B Psychol Sci Soc Sci 2009; 64 (Suppl 1): i86-i93.
25. Ford ES, Giles WH, Mokdad AH. The distribution of 10-year risk for coronary heart disease among US adults: findings from the National Health and Nutrition Examination Survey III. J Am Coll Cardiol 2004; 43(10): 1791-1796.
26. Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW. Can comorbidity be measured by questionnaire rather than medical record review? Med Care 1996; 34(1): 73-84.
27. Website UCB. Poverty thresholds 2006; http://www.census.gov/hhes/www/ poverty/threshld/thresh06.html
28. Rao J, Scott AJ. On chi-squared tests for multiway contingency tables with cell proportions estimated from survey data. Annals of Statistics 1984; 12: 46-60.
29. Zhang J, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 1998; 280(19): 1690-1691.
30. The National, Social Life, Health and Aging (NSHAP) Dataset. http://www.icpsr.umich.edu/NACDA/news.html#nshap/
31. Stata Statistical Software (computer program). Version 10.1. College Station, TX: StataCorp LP; 2008.
32. Stafford RS, Monti V, Ma J. Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease. PLoS Med 2005; 2(12): e353.
33. Ansell BJ, Watson KE, Fogelman AM. An evidence-based assessment of the NCEPAdult Treatment Panel II guidelines. National Cholesterol Education Program. JAMA 1999; 282(21): 2051-2057.
34. Gellad WF, Haas JS, Safran DG. Race/ethnicity and nonadherence to prescription medications among seniors: results of a national study. J Gen Intern Med 2007; 22(11): 1572-1578.
35. Ma J, Stafford RS. Quality of US outpatient care: temporal changes and racial/ethnic disparities. Arch Intern Med 2005; 165(12): 1354-1361.
36. LaVeist TA. Racial segregation and longevity among African Americans: an individual-level analysis. Health Serv Res 2003; 38(6 Pt 2): 1719-1733.
37. Robert SA, Ruel E. Racial segregation and health disparities between Black and White older adults. J Gerontol B Psychol Sci Soc Sci 2006; 61(4): S203-211.
38. Gaskin DJ, Price A, Brandon DT, Laveist TA. Segregation and Disparities in Health Services Use. Med Care Res Rev 2009; 66(5): 578-579.
39. Musa D, Schulz R, Harris R, Silverman M, Thomas SB. Trust in the health care system and the use of preventive health services by older black and white adults. Am J Public Health 2009; 99(7): 1293-1299.
40. Fiscella K, Franks P, Doescher MP, Saver BG. Disparities in health care by race, ethnicity, and language among the insured: findings from a national sample. Med Care 2002; 40(1): 52-59.
41. Alkhenizan A. Aspirin for primary prevention. Doctors and patients should understand potential benefits and risks of aspirin treatment. BMJ 2000; 321(7274): 1472-1473.
42. Buring JE, Hennekens CH. Prevention of cardiovascular disease: risks and benefits of aspirin. J Gen Intern Med 1990; 5(5 Suppl): S54-57.
43. Stafford RSR, David C. The underutilization of cardiac medications of proven benefit. Journal of the American College of Cardiology. 2003; 41(1): 56-61.
44. Briesacher BA, Gurwitz JH, Soumerai SB. Patients at-risk for costrelated medication nonadherence: a review of the literature. J Gen Intern Med 2007; 22(6): 864-871.
45. Piette JD, Heisler M, Wagner TH. Cost-related medication underuse among chronically ill adults: the treatments people forgo, how often, and who is at risk. Am J Public Health 2004; 94(10): 1782-1787.
46. Alexander GC, Casalino LP, Meltzer DO. Patient-physician communication about out-of-pocket costs. JAMA 2003; 290(7): 953-958.
47. Eisenberg JM, Power EJ. Transforming insurance coverage into quality health care: voltage drops from potential to delivered quality. JAMA 2000; 284(16): 2100-2107.
48. Schneider EC, Zaslavsky AM, Epstein AM. Racial disparities in the quality of care for enrollees in medicare managed care. JAMA 2002; 287(10): 1288-1294.
49. Cagney KA, Browning CR, Wen M. Racial disparities in self-rated health at older ages: what difference does the neighborhood make? J Gerontol B Psychol Sci Soc Sci 2005; 60(4): S181-190.
50. Thorpe RJ Jr, Brandon DT, LaVeist TA. Social context as an explanation for race disparities in hypertension: findings from the Exploring Health Disparities in Integrated Communities (EHDIC) Study. Soc Sci Med 2008; 67(10): 1604-1611.
51. Pollack CE, Armstrong K. The geographic accessibility of retail clinics for underserved populations. Arch Intern Med 2009; 169(10): 945-949. (discussion 950-943).
52. Morrison RS, Wallenstein S, Natale DK, Senzel RS, Huang LL. "We don't carry that"-failure of pharmacies in predominantly nonwhite neighborhoods to stock opioid analgesics. N Engl J Med 2000; 342(14): 1023-1026.
53. Doescher MP, Saver BG, Fiscella K, Franks P., Racial/ethnic inequities in continuity and site of care: location, location, location. Health Serv Res 2001; 36(6 Pt 2): 78-89.
54. Gaskin DJ, Arbelaez JJ, Brown JR, Petras H, Wagner FA, Cooper LA., Examining racial and ethnic disparities in site of usual source of care. J Natl Med Assoc. Jan 2007; 99(1): 22-30.